Answers are grounded in this paper and cite their sources.
Visceral leishmaniasis (VL), a severe parasitic infection caused by Leishmania species, presents a significant challenge due to its potential for relapse despite treatment. This review aims to rationalize antirelapse therapies for VL and address diagnostic dilemmas encountered in therapeutic assessment. By evaluating current treatment strategies, examining relapse mechanisms, and highlighting diagnostic challenges, we aim to provide a comprehensive understanding of effective management and assessment of VL relapse.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: